PHARMACOLOGY, BIOCHEMISTRY AND PHYSIOLOGY OF CENTRAL NEUROTRANSMITTERS
PHARMACOLOGY, BIOCHEMISTRY AND PHYSIOLOGY OF CENTRAL NEUROTRANSMITTERS
批准号:
3846189
负责人:
T N CHASE
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
Alzheimer's disease NMDA receptors Parkinson's disease Tourette's syndrome antiparkinson drugs cellular respiration dihydroxyphenylalanine dopamine dopamine receptor dosage drug administration rate /duration drug adverse effect extrapyramidal disorder human old age (65+) human subject human therapy evaluation human tissue intravenous administration laboratory rat nervous system disorder chemotherapy neural degeneration neuropharmacology neurophysiology physostigmine positron emission tomography receptor sensitivity scopolamine
中文摘要
点击翻译按钮获取中文摘要
英文摘要
1. The interval from the onset of symptoms to the introduction of
levodopa was unrelated to the time from levodopa initiation to motor
complication onset. There no longer appears to be a rational basis for
delaying levodopa therapy in parkinsonian patients.
2. Motor response complications reflect striatal system changes due to
dopaminergic deafferentation and intermittent dopaminomimetic treatment
and tend to normalize with the more physiologic stimulation afforded by
continuous replacement strategies.
3. Glutamatergic mechanisms affect extrapyramidal motor function: In
rats, D-2 mediated responses require concurrent NMDA receptor
stimulation, while D-1 receptor-regulated pathways have varying degrees
of sensitivity to NMDA receptor blockade; the subthalamic nucleus
contributes primarily to the expression of D-2 mediated motor behaviors.
In patients with Parkinson's disease, glutamatergic stimulation with
milacemide transiently increased overall parkinsonian severity,
especially rigidity.
4. No generalized defect in mitochondrial respiratory function could be
documented in Parkinson's disease: oxygen consumption rates and
respiratory chain enzyme activities in platelets and muscle mitochondria
as well as blood lactate levels following glucose loading did not differ
significantly between patients and controls.
5. Tourette syndrome patients have marked decreases in ventral brain
areas, increases along the superior cortical convexities, and inverted
relationships between these limbic and sensorimotor cortical regions
appear on PET-fluorodeoxyglucose scans.
6. Physostigmine by continuous intravenous infusion at maximum tolerated
levels inhibits CSF acetylcholinesterase by only 21% and produces little
cognitive benefit. Amnestic doses of the anticholinergic, scopolamine,
increase cortical function in normal elderly subjects in contrast to the
decreases, especially parietotemporal, in PET scans of Alzheimer
patients. Physostigmine, rather than normalizing, marginally diminishes
cortical metabolism.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PHARMACOLOGY, BIOCHEMISTRY AND PHYSIOLOGY OF CENTRAL NEUROTRANSMITTERS
-
批准号:3782322
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:T N CHASE
-
依托单位:
PHARMACOLOGY, BIOCHEMISTRY AND PHYSIOLOGY OF CENTRAL NEUROTRANSMITTERS
-
批准号:3922512
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:T N CHASE
-
依托单位:
PHARMACOLOGY, BIOCHEMISTRY AND PHYSIOLOGY OF CENTRAL NEUROTRANSMITTERS
-
批准号:3760239
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:T N CHASE
-
依托单位:
PHARMACOLOGY, BIOCHEMISTRY AND PHYSIOLOGY OF CENTRAL NEUROTRANSMITTERS
-
批准号:4696849
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:T N CHASE
-
依托单位:
PHARMACOLOGY, BIOCHEMISTRY AND PHYSIOLOGY OF CENTRAL NEUROTRANSMITTERS
-
批准号:3860789
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:T N CHASE
-
依托单位:
PHARMACOLOGY, BIOCHEMISTRY AND PHYSIOLOGY OF CENTRAL NEUROTRANSMITTERS
-
批准号:3968948
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:T N CHASE
-
依托单位:
PATHOGENESIS AND TREATMENT OF NEURODEGENERATIVE DISEASE
-
批准号:6163000
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:T N CHASE
-
依托单位:
PHARMACOLOGY, BIOCHEMISTRY AND PHYSIOLOGY OF CENTRAL NEUROTRANSMITTERS
-
批准号:5203899
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:T N CHASE
-
依托单位:
PATHOGENESIS AND TREATMENT OF NEURODEGENERATIVE DISEASE
-
批准号:2579533
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:T N CHASE
-
依托单位:
海外基金